PCN85 SORAFENIB AND SUNITINIB IN METASTATIC RENAL CELL CARCINOMA- COST-EFFECTIVENESS ANALYSIS IN REIMBURSEMENT PROCEEDINGS VS. DATA FROM CLINICAL PRACTICE
Abstract
Authors
B Ondrackova R Demlova
B Ondrackova R Demlova
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now